COMP <GO>
TLRY vs OBIO // PIOTROSKI F-SCORE QUALITY
Tilray Brands Inc. (NASDAQ) VS. Orchestra BioMed Holdings Inc. (NASDAQ) • 15-METRIC TALLY: TLRY 4
— OBIO 4
■ METRIC PARITY
LAST: $2.64 (-1.86%) • MKT CAP: $390.2M
piotroski-score
5/9
LAST: $6.09 (+1.67%) • MKT CAP: $366.0M
piotroski-score
5/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TLRY VS. OBIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TLRY | OBIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.40% | 96.00% | -67.60 | OBIO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.90% | -35.00% | +31.10 | TLRY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.72% | -13.51% | -4.21 | OBIO | /fcf-yield <GO> |
| Operating Margin | -6.90% | -60.00% | +53.10 | TLRY | /operating-margins <GO> |
| Net Profit Margin | -13.30% | -60.00% | +46.70 | TLRY | /net-margins <GO> |
| Revenue Growth (YoY) | 11.50% | 180.00% | -168.50 | OBIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 25.8 | 57.3 | -31.50 | OBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $390.2M | $366.0M | $24.1M | TLRY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TLRY REV | OBIO REV | TLRY GROSS % | OBIO GROSS % | TLRY FCF | OBIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $915.5M | $33.5M | 28.4% | 98.0% | -$69.1M | -$49.5M |
| FY 2024 | $821.3M | $2.6M | 29.3% | 92.3% | -$94.6M | -$50.8M |
| FY 2023 | $788.9M | $2.8M | — | — | -$30.9M | -$46.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TLRY // BETA —
OBIO // BETA —